Login
Home / BMNDF : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Biomind Labs Inc.

$0.25 +$0.14 (+119.56%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.25
Day Range
$0.25$0.6
Year Range
$0.01$0.8
Market Cap
19.42M
AVG Volume
5.63K
Trailing/Forward PE
-13.31/-
PEG ratio
2.69
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
00.250.50.75124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (USD)
-750K-500K-250K0250K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (USD)
-800K-600K-400K-200K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (USD)
-800K-600K-400K-200K0200K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (USD)
-150K-100K-50K050K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (USD)
-0.01-0.0100.0124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (USD)
-200K0200K400K600K800KR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (USD)
0500K1M1.5MCashShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-6-4-2024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%25%50%75%100%19 Q119 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q2
Return on Capital
-20%0%20%40%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (USD)
00.020.040.060.08Oct 18Dec 19Nov 20
Book Value Per Share (USD)
-0.03-0.02-0.01024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (USD)
020K40K60K80K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Free Cash Flow Yield
-20%-15%-10%-5%0%med -1.48%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
-1500000-1000000-5000000med -22530.49Sep 21Nov 21Feb 22Apr 22Jul 22Sep 22
Price to Book
0100200300med 34.09Jan 22Apr 22Jun 22Aug 22Nov 22Jan 23Mar 23
Biomind Labs Inc.
BMNDF
Stockpicker

Video analysis: BMNDF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BMNDF

Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada

accessnewswire.com · 6 Aug 2026

Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada

VANCOUVER, BC / ACCESS Newswire / August 6, 2026 / Biomind Labs Inc. ("Biomind" or the "Company") (CBOE:BMND) (OTC PINK:BMNDF), a clinical-stage biopharmaceutical company focused on transforming breakthroughs in neuroscience and biomedical research into novel pharmaceutical drugs, is pleased to announce that it has received approval to list its common shares (the "Common Shares") on the Canadian Securities Exchange (the "CSE"), and the Common Shares will commence trading on the CSE at market open on August 11, 2026 under the symbol "BMND". In connection with the listing of the Common Shares on the CSE, the Company will be delisting its Common Shares from the Cboe Canada (the "Cboe") effective close of business on August 10, 2026.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.